- Home
- GOOD vs HQL Comparison
GOOD vs HQL Comparison
Compare GOOD & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOOD | HQL |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | 72 | N/A |
| Industry | Real Estate Investment Trusts | Investment Managers |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 594.9M | 507.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOOD | HQL |
|---|---|---|
| Price | $12.50 | $17.85 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 390.3K | 108.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | 9.64% | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.37 | N/A |
| Revenue Next Year | $2.56 | N/A |
| P/E Ratio | $62.41 | ★ $22.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.33 | $11.72 |
| 52 Week High | $14.70 | $17.96 |
Technical Indicators
Market Signals| Indicator | GOOD | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 66.27 | 69.00 |
| Support Level | $12.09 | $16.40 |
| Resistance Level | $13.44 | N/A |
| Average True Range (ATR) | 0.21 | 0.35 |
| MACD | 0.11 | 0.14 |
| Stochastic Oscillator | 93.75 | 95.33 |
Price Performance
Historical ComparisonAbout GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.